DIABETIC MACULAR OEDEMA

Clinical trials for DIABETIC MACULAR OEDEMA explained in plain language.

Never miss a new study

Get alerted when new DIABETIC MACULAR OEDEMA trials appear

Sign up with your email to follow new studies for DIABETIC MACULAR OEDEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New eye injection shows promise for Diabetes-Related vision loss

Disease control Ongoing

This study tests a new eye injection called IBI302 for people with diabetic macular edema, a condition that causes vision loss due to diabetes. About 150 adults aged 18-80 with type 1 or 2 diabetes and swelling in the center of the retina will receive either IBI302 or an active c…

Matched conditions: DIABETIC MACULAR OEDEMA

Phase: PHASE2 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

DIABETIC MACULAR OEDEMA

Get alerted when new DIABETIC MACULAR OEDEMA trials appear

New eye injection shows promise for Diabetes-Related vision loss